Gene: ZBTB20

26137
DPZF|HOF|ODA-8S|PRIMS|ZNF288
zinc finger and BTB domain containing 20
protein-coding
3q13.31
Ensembl:ENSG00000181722 MIM:606025 Vega:OTTHUMG00000159366 UniprotKB:Q9HC78
NG_052992.1
PubMed
0   ANCO-SNPs
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.928e-1 (AD)  1.790e-2 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PRR260.836
ZNF4600.832
TAS2R300.815
OR56A40.815
PRAMEF170.813
MTRNR2L50.802
OR10K10.799
TMEM2470.798
NBEAL10.798
PRDM140.798

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HENMT1-0.484
C11orf80-0.453
VSTM5-0.439
MCF2-0.435
SMPX-0.426
ACRV1-0.423
STYK1-0.421
KRT222-0.42
FAM19A2-0.416
NELL1-0.416

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA"25510870
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of ZBTB20 mRNA"21346803
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ZBTB20 mRNA"28973690
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
C0275764-hydroxy-2-nonenal4-hydroxy-2-nonenal results in increased expression of ZBTB20 mRNA19191707
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of ZBTB20 mRNA21420995
D000082AcetaminophenAcetaminophen results in increased expression of ZBTB20 mRNA26690555
D000082AcetaminophenAcetaminophen affects the expression of ZBTB20 mRNA17562736
D020106AcrylamideAcrylamide results in decreased expression of ZBTB20 mRNA28959563
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of ZBTB20 mRNA22100608
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of ZBTB20 gene27153756
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of ZBTB20 mRNA21641981
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of ZBTB20 mRNA19770486
D000393Air PollutantsAir Pollutants analog results in decreased expression of ZBTB20 mRNA21757418
D001104ArbutinArbutin results in increased expression of ZBTB20 mRNA17103032
D001151ArsenicArsenic affects the methylation of ZBTB20 gene25304211
D001280AtrazineAtrazine results in increased expression of ZBTB20 mRNA22378314
C030935benz(a)anthracenebenz(a)anthracene affects the expression of ZBTB20 mRNA26377693
C006703benzo(b)fluoranthenebenzo(b)fluoranthene results in decreased expression of ZBTB20 mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of ZBTB20 mRNA19770486
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZBTB20 mRNA"20018196
D001663BilirubinBilirubin results in decreased expression of ZBTB20 mRNA20196124
C543008bis(4-hydroxyphenyl)sulfone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB20 mRNA28628672
C006780bisphenol Abisphenol A results in decreased expression of ZBTB20 mRNA22576693
C006780bisphenol Abisphenol A results in increased methylation of ZBTB20 gene22576693
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZBTB20 mRNA28628672
C006780bisphenol Abisphenol A results in decreased expression of ZBTB20 mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of ZBTB20 gene28505145
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZBTB20 mRNA28628672
D002065BuspironeBuspirone results in increased expression of ZBTB20 mRNA24136188
C018475butyraldehydebutyraldehyde results in decreased expression of ZBTB20 mRNA26079696
D002737ChloropreneChloroprene results in increased expression of ZBTB20 mRNA23125180
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZBTB20 mRNA20938992
D003300Copper[NSC 689534 binds to Copper] which results in increased expression of ZBTB20 mRNA20971185
D019327Copper SulfateCopper Sulfate results in increased expression of ZBTB20 mRNA19549813
D003471CuprizoneCuprizone results in decreased expression of ZBTB20 mRNA26577399
D016572CyclosporineCyclosporine results in decreased expression of ZBTB20 mRNA27989131
D016572CyclosporineCyclosporine results in increased expression of ZBTB20 mRNA25562108
D016572CyclosporineCyclosporine results in increased methylation of ZBTB20 promoter27989131
D016572CyclosporineCyclosporine results in increased expression of ZBTB20 mRNA19770486
D003630DaunorubicinZBTB20 affects the susceptibility to Daunorubicin17545624
C010902decabromobiphenyl etherdecabromobiphenyl ether results in decreased expression of ZBTB20 mRNA23640034
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB20 mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZBTB20 mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZBTB20 mRNA28628672
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of ZBTB20 mRNA21266533
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of ZBTB20 mRNA21266533
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of ZBTB20 mRNA21266533
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of ZBTB20 mRNA27392435
D002945CisplatinCisplatin results in decreased expression of ZBTB20 mRNA27392435|2759478
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ZBTB20 mRNA"22485181
D004237DiuronDiuron results in decreased expression of ZBTB20 mRNA25152437
D004317DoxorubicinDoxorubicin results in decreased expression of ZBTB20 mRNA19277126
C118739entinostatentinostat results in decreased expression of ZBTB20 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of ZBTB20 mRNA17557909
C024565ethylene dichlorideethylene dichloride results in decreased expression of ZBTB20 mRNA28189721
D018120FinasterideFinasteride results in increased expression of ZBTB20 mRNA24136188
D005472FluorouracilFluorouracil results in decreased expression of ZBTB20 mRNA16510598
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZBTB20 mRNA20938992
C069837fullerene C60fullerene C60 results in increased expression of ZBTB20 mRNA19167457
D005897GlafenineGlafenine results in decreased expression of ZBTB20 mRNA24136188
C492448ICG 001ICG 001 results in decreased expression of ZBTB20 mRNA26191083
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB20 mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZBTB20 mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZBTB20 mRNA28628672
D007213IndomethacinIndomethacin results in decreased expression of ZBTB20 mRNA28201806
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ZBTB20 mRNA25613284
C051890irinotecanirinotecan analog results in decreased expression of ZBTB20 mRNA18927307
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ZBTB20 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZBTB20 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZBTB20 mRNA28628672
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of ZBTB20 mRNA27392435
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of ZBTB20 mRNA26752646
C410337K 7174K 7174 results in increased expression of ZBTB20 mRNA24086573
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in increased expression of ZBTB20 mRNA"24972896
D058185Magnetite Nanoparticles[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB20 mRNA21641980
D058185Magnetite Nanoparticles[Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZBTB20 mRNA26378955
D008558MelphalanMelphalan results in decreased expression of ZBTB20 mRNA22363485
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZBTB20 mRNA20938992
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of ZBTB20 mRNA26272509|2800136
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of ZBTB20 mRNA23179753
C004925methylmercuric chloride"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of ZBTB20 mRNA26011545
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of ZBTB20 mRNA23649840
D008777MethyltestosteroneMethyltestosterone results in increased expression of ZBTB20 mRNA29191790
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of ZBTB20 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of ZBTB20 mRNA"25554681
C017096n-butoxyethanoln-butoxyethanol results in decreased expression of ZBTB20 mRNA19812364
C051752nefazodonenefazodone results in decreased expression of ZBTB20 mRNA24136188
D009532NickelNickel results in decreased expression of ZBTB20 mRNA24768652|2558310
C558013NSC 689534[NSC 689534 binds to Copper] which results in increased expression of ZBTB20 mRNA20971185
D010100OxygenOxygen deficiency results in increased expression of ZBTB20 mRNA24205000
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA"25510870
C568608PCI 5002[PCI 5002 co-treated with Zinc] results in increased expression of ZBTB20 mRNA18593933
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of ZBTB20 mRNA27153767
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of ZBTB20 mRNA25868421
D010634PhenobarbitalPhenobarbital affects the expression of ZBTB20 mRNA23091169
C006253pirinixic acidpirinixic acid results in decreased expression of ZBTB20 mRNA23811191
C006253pirinixic acidpirinixic acid results in increased expression of ZBTB20 mRNA16985257
C045950propiconazolepropiconazole results in decreased expression of ZBTB20 mRNA21278054
C513428pyrachlostrobinpyrachlostrobin results in increased expression of ZBTB20 mRNA27029645
C031389resorcinolresorcinol results in decreased expression of ZBTB20 mRNA22623647
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of ZBTB20 mRNA23806026
D012834SilverSilver results in increased expression of ZBTB20 mRNA26014281
C009277sodium arsenatesodium arsenate results in decreased expression of ZBTB20 mRNA21795629
C009277sodium arsenatesodium arsenate results in increased expression of ZBTB20 mRNA21795629
C017947sodium arsenitesodium arsenite affects the methylation of ZBTB20 gene28589171
C017947sodium arsenitesodium arsenite results in increased expression of ZBTB20 mRNA22714537
D020058StyreneStyrene results in decreased expression of ZBTB20 mRNA28951217
D004113Succimer[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB20 mRNA21641980
D004113Succimer[Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZBTB20 mRNA26378955
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of ZBTB20 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of ZBTB20 mRNA21354282
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of ZBTB20 mRNA22298810
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ZBTB20 mRNA25613284
D013792ThalidomideThalidomide results in increased expression of ZBTB20 mRNA28892372
D013853ThioacetamideThioacetamide results in decreased expression of ZBTB20 mRNA23411599
C009495titanium dioxidetitanium dioxide results in decreased expression of ZBTB20 mRNA27760801
D014212TretinoinTretinoin results in increased expression of ZBTB20 mRNA23724009
D014241TrichloroethyleneTrichloroethylene results in increased expression of ZBTB20 mRNA19448997
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of ZBTB20 mRNA"26179874
C057693troglitazonetroglitazone results in decreased expression of ZBTB20 mRNA28973697
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB20 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of ZBTB20 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of ZBTB20 mRNA23179753|2493525
D014638VanadatesVanadates results in decreased expression of ZBTB20 mRNA22714537
D001335Vehicle EmissionsVehicle Emissions affects the methylation of ZBTB20 gene25560391
D014810Vitamin EVitamin E results in decreased expression of ZBTB20 mRNA19244175
D015032Zinc[PCI 5002 co-treated with Zinc] results in increased expression of ZBTB20 mRNA18593933
D019287Zinc SulfateZinc Sulfate results in increased expression of ZBTB20 mRNA27504894

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding-ISA-  
GO:0001078transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding-IEA-  
GO:0003677DNA binding-IEA-  
GO:0046872metal ion binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000122negative regulation of transcription by RNA polymerase II-IEA-  
GO:0006351transcription, DNA-templated-IEA-  
GO:0032728positive regulation of interferon-beta production-IEA-  
GO:0032755positive regulation of interleukin-6 production-IEA-  
GO:0032760positive regulation of tumor necrosis factor production-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IDA-  
GO:0005654nucleoplasm-IDA-  
GO:0016604nuclear body-IDA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
23861218Genetic variations in the PRKAA1 and ZBTB20 genes and gastric cancer susceptibility in a Korean population. (2013 Nov)Song HRMol Carcinog